Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Profit from core business operations before interest and taxes
Latest
$-46.23M
Near historical average
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-46.78M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-46.23M | +19.3% |
| 2024 | $-57.28M | -65.5% |
| 2023 | $-34.62M | +33.4% |
| 2022 | $-52.02M | +42.4% |
| 2021 | $-90.32M | -14.5% |
| 2020 | $-78.89M | -101.4% |
| 2019 | $-39.17M | -223.2% |
| 2018 | $-12.12M | -16.9% |
| 2017 | $-10.37M | - |